235 related articles for article (PubMed ID: 36310858)
41. Diagnostic and prognostic value of serum L1-cell adhesion molecule in esophageal squamous cell carcinoma.
Xu YW; Hong CQ; Wu ZY; Peng YH; Ran LQ; Yang SH; Huang BS; Liang XY; Chen HL; Wu JY; Xu XE; Deng JW; Zou HY; Fang WK; Li EM; Xu LY; Xie JJ
Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):597-603. PubMed ID: 30219694
[TBL] [Abstract][Full Text] [Related]
42. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
Cui Y; Xue Y; Dong S; Zhang P
J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538
[TBL] [Abstract][Full Text] [Related]
43. Salivary Porphyromonas gingivalis predicts outcome in oral squamous cell carcinomas: a cohort study.
Chen Q; Shao Z; Liu K; Zhou X; Wang L; Jiang E; Luo T; Shang Z
BMC Oral Health; 2021 May; 21(1):228. PubMed ID: 33941164
[TBL] [Abstract][Full Text] [Related]
44. Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
Wang W; He X; Zheng Z; Ma X; Hu X; Wu D; Wang M
Mol Cancer; 2017 Apr; 16(1):75. PubMed ID: 28376832
[TBL] [Abstract][Full Text] [Related]
45. Diagnosis of Esophageal Squamous Cell Carcinoma by High-Performance Serum Metabolic Fingerprints: A Retrospective Study.
Huang Y; Yang H; Li J; Wang F; Liu W; Liu Y; Wang R; Duan L; Wu J; Gao Z; Cao J; Bian F; Zhang J; Zhao F; Yang S; Cao S; Yang A; Wang X; Geng M; Hao A; Li J; Cao J; Li C; Zhang Z; Zhang N; Huang Y; Zhang Y; Qian K; Zhou F
Small Methods; 2024 Jan; 8(1):e2301046. PubMed ID: 37803160
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic performance of anti-MAGEA family protein autoantibodies in esophageal squamous cell carcinoma.
Sun G; Chen H; Xia J; Li T; Ye H; Li J; Zhang X; Cheng Y; Wang K; Shi J; Wang P
Int Immunopharmacol; 2023 Dec; 125(Pt A):111041. PubMed ID: 37866309
[TBL] [Abstract][Full Text] [Related]
47. Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
Tang X; Fan Z; Wang Y; Ji G; Wang M; Lin J; Huang S
Dis Esophagus; 2016 Apr; 29(3):207-14. PubMed ID: 25287007
[TBL] [Abstract][Full Text] [Related]
48. The role of microbiota in esophageal squamous cell carcinoma: A review of the literature.
Chiang HC; Hughes M; Chang WL
Thorac Cancer; 2023 Oct; 14(28):2821-2829. PubMed ID: 37675608
[TBL] [Abstract][Full Text] [Related]
49. Towards Tyrosine Metabolism in Esophageal Squamous Cell Carcinoma.
Cheng J; Zheng G; Jin H; Gao X
Comb Chem High Throughput Screen; 2017; 20(2):133-139. PubMed ID: 28000565
[TBL] [Abstract][Full Text] [Related]
50. Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers.
Xu J; Chen Y; Zhang R; Song Y; Cao J; Bi N; Wang J; He J; Bai J; Dong L; Wang L; Zhan Q; Abliz Z
Mol Cell Proteomics; 2013 May; 12(5):1306-18. PubMed ID: 23397110
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-196a as a Potential Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma.
Fendereski M; Zia MF; Shafiee M; Safari F; Saneie MH; Tavassoli M
Cancer Invest; 2017 Feb; 35(2):78-84. PubMed ID: 28095062
[TBL] [Abstract][Full Text] [Related]
52. Mechanism of intestinal microbiota disturbance promoting the occurrence and development of esophageal squamous cell carcinoma--based on microbiomics and metabolomics.
Huang X; Chen X; Wan G; Yang D; Zhu D; Jia L; Zheng J
BMC Cancer; 2024 Feb; 24(1):245. PubMed ID: 38388357
[TBL] [Abstract][Full Text] [Related]
53. Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma.
Dong S; Yin H; Dong C; Sun K; Lv P; Meng W; Ming L; He F
Dis Markers; 2016; 2016():1857067. PubMed ID: 26989293
[TBL] [Abstract][Full Text] [Related]
54. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
[TBL] [Abstract][Full Text] [Related]
55. Oral infectious bacteria in dental plaque and saliva as risk factors in patients with esophageal cancer.
Kawasaki M; Ikeda Y; Ikeda E; Takahashi M; Tanaka D; Nakajima Y; Arakawa S; Izumi Y; Miyake S
Cancer; 2021 Feb; 127(4):512-519. PubMed ID: 33156979
[TBL] [Abstract][Full Text] [Related]
56. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
[TBL] [Abstract][Full Text] [Related]
57. Alterations of salivary microbial community associated with oropharyngeal and hypopharyngeal squamous cell carcinoma patients.
Panda M; Rai AK; Rahman T; Das A; Das R; Sarma A; Kataki AC; Chattopadhyay I
Arch Microbiol; 2020 May; 202(4):785-805. PubMed ID: 31832691
[TBL] [Abstract][Full Text] [Related]
58. [Comparative study on metagenomics of esophageal flora in elderly and middle-aged esophageal squamous cell carcinoma patients].
Liu XB; Gao ZY; Jin S; Gao B; Wang MS; Wu T; Li SB; Tong Q; Zhang JC
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Mar; 55(3):371-378. PubMed ID: 33730830
[No Abstract] [Full Text] [Related]
59. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
[TBL] [Abstract][Full Text] [Related]
60. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
